Melanotic Neuroectodermal Tumour of Infancy

Area of Science:

• Pediatric Oncology
• Oral and Maxillofacial Pathology
• Developmental Biology

Background:

• Melanotic neuroectodermal tumour of infancy (MNTI) is a rare, locally aggressive neoplasm originating from neural crest cells.
• Predominantly affecting infants under one year old, MNTI typically manifests in the head and neck, particularly the anterior maxilla.
• Histologically, it presents a biphasic pattern of neuroblastic and pigmented epithelial cells, which can mimic malignancy due to rapid growth.

Purpose of the Study:

• To discuss the clinical findings, histopathological features, and differential diagnosis of melanotic neuroectodermal tumour of infancy.
• To emphasize the importance of early diagnosis for effective management of MNTI.
• To highlight the challenges in surgical treatment and reconstruction for MNTI in infants.

Main Methods:

• Review of clinical presentation and histopathological characteristics of MNTI.
• Discussion of differential diagnoses for pediatric head and neck tumors.
• Analysis of treatment strategies and potential complications.

Main Results:

• MNTI is characterized by rapid growth and potential invasion of adjacent tissues, leading to diagnostic challenges.
• Surgical excision is the primary treatment, often curative.
• Extensive surgery can impact facial growth and development, necessitating careful planning and reconstruction.

Conclusions:

• Early and accurate diagnosis of MNTI is critical for optimal outcomes in infants.
• Understanding the clinical and histopathological features aids in differentiating MNTI from other pediatric neoplasms.
• While generally benign, the aggressive behavior of MNTI requires prompt and appropriate management to minimize morbidity.